kainaatmalhotra
10+ Views

Angiographic Catheter Market Evolving Opportunities with Innovative Ideas by Key Players |2018-2025

Market Analysis: Global Angiographic Catheter Market
Angiographic Catheter Market is expected to reach USD 1720.03 Million by 2025 from USD 978.9 million in 2017 growing at a CAGR of 7.3% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2017, the base year of calculation is 2017 and the forecast period is 2018 to 2025
Market Definition: Global Angiographic Catheter Market
Angiography is a medical imaging technique to visualize, diagnose and treat the medical conditions. Angiography is mainly done with the device known as catheter. Angiographic catheters are used in various medical cases like micro-angiography, neurovascular angiography, peripheral angiography and many others. Angiographic catheters are basically made from the polyamide, polyethylene, polyurethane, and polytetrafluoroethylene Angiography is performed using X-Ray catheters, computed tomography and magnetic resonance imaging. Physicians use the procedure in case of aneurysms, detection of atherosclerotic disease, arteriovenous malformation. The main advantage of angiography is that it eliminates the need of surgery. Catheter angiography presents the detailed clear and accurate images of the blood vessels. In computed tomography and magnetic resonance imaging catheter make the possible combination of diagnosis and treatment. As per of National Interventional Council (NIC), in India the number of coronary angioplasties performed has increased to 42% in 2015 as compared to 2014, which is in proportion with the rise of coronary artery diseases in the country. In April 2018, Terumo will launch Ultimaster TANSEI in Europe in May and the company also looking for expanding their business in other countries like Middle East, Latin America, and Asia.
Major Market Drivers and Restraints:
Increase in the incidence of cardiovascular disease.
Increase in the demand for catheter for angiography procedures.
Rise in geriatric population
Technology advancement in the development of new catheter
Lack of awareness towards catheter in angioplasty
Downward pricing pressure owing to its commodity nature

Market Segmentation: Global Angiographic Catheter Market
The angiographic catheter market is segmented into application and end users.
Based on application, the market is segmented into endovascular, neurology, oncology and others.
Based on end users, the market is segmented into hospitals, cardiac centers, and brain centers.
Based on geography the angiographic catheter market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others

Competitive Analysis: Global Angiographic Catheter Market
Global angiographic catheter market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market. The report includes market shares of angiographic catheter system market for global, Europe, North America, Asia Pacific and South America.
Major Market competitors/players: Global Angiographic Catheter Market
Some of the major players operating in the angiographic catheter market are Boston Scientific, C. R. Bard, Medtronic, Aachen Resonance, Abbott Laboratories, Abiomed, Acrostak, AdvanSource Biomaterials, AGA Medical, Allium Medical, Alvimedica, AMG International, AngioDynamics, Angioslide, Arstasis, Arthesys, Asahi Intecc, Atrium Medical, AV Medical, B. Braun Melsungen, Beijing Puyishengji Medical Technology, Biophan Technologies, Biosense Webster, Biotronik, BrosMed, Cardiac Science, CardiacAssist, Dextera Surgical, Cardio-Flow, Cardionovum, Claret Medical, Contego Medical among others.
Research Methodology: Global Angiographic Catheter Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.
Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others
Browse Trending Related Reports @
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Comment
Suggested
Recent
Cards you may also be interested in
Significant Impact of COVID-19 on Bulk Material Handling System in Semiconductors & Electronics Industry
COVID-19 Impact on Bulk Material Handling System in Semiconductors and Electronics Industry The lockdown situation during the COVID-19 pandemic has highly impacted the global economy. Most of the governments from different countries imposed a lockdown to break the chain of coronavirus spread. All companies related to various industries have been shut down except a few dealing with COVID-19 operations such as pharmaceutical, essential goods and services and the food industry. As a result of the COVID-19 crisis, many bulk material handling companies throughout the world have had to either temporarily close or reduce their workforces to prevent the spread of the virus. Through worldwide shortages of goods, it soon was apparent how important the world’s manufacturing and warehouse productivity is to the economy. In the bulk material handling system market, the business impact eventually proved to be less severe than first anticipated once lockdowns and restrictions were lifted. Nevertheless, the limited access to customers’ sites affected both capital and aftermarket sales of suppliers throughout the year. The COVID-19 pandemic highlighted that automation is needed for supply chains to increase efficiency. During the recent period, very few percent of supply chains felt fully prepared for the coronavirus impact. However, the bulk material handling industry can develop this situation with innovation, automation and perseverance. AFTERMATH OF GLOBAL BULK MATERIAL HANDLING SYSTEM MARKET COVID-19 pandemic affected a wide range of industries, from small to large manufacturing companies. It hampered the worldwide demand for solutions in the bulk material handling system market up to a certain extent. Limited workforce and operational restrictions negatively affected the product development life cycle. But at later stages, when lockdown restrictions were lifted, demand got stable up to a certain point. The companies developed different strategies and technologies specific to tackle problems that occurred because of the COVID-19 pandemic. For instance, · Daifuku Co., Ltd., a material handling company, stated some measures and strategies to overcome the challenges faced during the COVID-19 pandemic in their annual report 2020. To prevent the spread of COVID-19 and maintain distance from one another required a new approach to service activities for systems post-delivery. Accordingly, they are working hard to use the Internet of Things (IoT), artificial intelligence (AI) and information and communications technology (ICT) to establish material handling systems that never stop or that will be able to recover immediately even if blocked. They will continue to support stable operations of customer facilities by introducing new technologies and services, including remote operation, while ensuring the lives, safety and health of employees and their families. Likewise, many companies have started introducing new technologies and methodologies in the COVID-19 situation to remain better positioned in the market. Losses during this period can be overcome in the future by taking this slowdown to redesign and refresh the business processes and logistics operations. OPPORTUNITIES FOR THE MARKET IN COVID-19 SITUATION Market players have an opportunity to upgrade their operations and prospective for the betterment of their companies. Automation is the key to success in this unpredictable world. Different crises, labour shortages, natural disasters impact a lot on every industry. So being one step ahead of time and understanding the market well will ensure the success of the market player. In this COVID-19 pandemic, many companies adopted process automation and customization as an opportunity to survive and grow. Some of the instances are mentioned below: § Automation to overcome labor shortage: Though recent events have worsened the labor gap, the labor shortage is not new for many industries, as more workers retire and skills requirements increase. Automation offers solutions to some of these problems. Automated Process Equipment Corporation provides solutions and services for bulk material handling companies to overcome labor shortages during this pandemic situation. Super sack handling, accurate measuring, automatic routing, easily reprogrammable controls and electronic record keeping are solutions that will improve automation and reduce the dependency on the massive number of laborers. § Customized Solutions for Booming Market: KWS Manufacturing Company Ltd. partnered up with Coperion K-Tron to provide the solution for the world’s most significant high-density polyethylene and polypropylene suppliers, which is used in consumer and industrial goods ranging from plastic bags and bottles to N95 medical masks and face shields. Due to the increased demand for polyethylene and polypropylene, expanding the client’s extrusion line required new loss-in-weight additive feeders and a mixing screw conveyor. KWS and Coperion K-Tron sales and engineering teams collaborated to ensure the extrusion line expansion would be successful. IMPACT ON SUPPLY AND DEMAND COVID-19 has disrupted the supply chain on a global scale. International trade restrictions and customs regulations resulted in longer wait times and a lack of capacity for long-haul deliverables. During this pandemic, the demand for bulk material handling solutions decreased because of the limited access to customers’ sites. This affected both capital and aftermarket sales throughout the year. Most of the companies faced challenges in managing on-time project completion and order deliveries. However, many companies took this to redesign their operation and logistic models with digital capabilities to increase operational efficiency and effectiveness in such a period. For instance, · ThyssenKrupp AG Company adopted the digitization of their business processes and supply chains in 2019-2020. Their focus was on the introduction of automation solutions which included the new mobile app “Paperless”. This app allowed digitizing day-to-day processes in warehouses such as bookings, preparation of work schedules and material identification. It also created the conditions for using other automation solutions, such as driverless transportation systems, to be used in a new state-of-the-art logistics center for ThyssenKrupp Schulte. Such positive changes and automation in the supply chain will enable the companies to emerge stronger and supply chains that are more resilient to future disruptions. CONCLUSION The global bulk material handling system market suffered losses during the recent period because of COVID-19’s negative impact on global demand and supply chains. Yearly sales for the market-related products got hampered due to limited access to customer’s sites. But relaxation in lockdown regulations after few months helped the market to somewhat come back on track. However, many companies started building new technologies to overcome supply chain problems in pandemic situations. They adopted digitization and automation in day-to-day business processes and supply chains. Although it will take some more time for companies to come back on track, this period made everyone realize the need for up-gradation in many business aspects.
Significant COVID-19 Impact on Non-Small Cell Lung Cancer Diagnostics in Healthcare Industry
COVID-19 Impact on Non-Small Cell Lung Cancer Diagnostics in Healthcare Industry The novel coronavirus has profoundly impacted all fields, including healthcare, medical device services, automotive, pharmaceutical and many others. This pandemic has led to shutdowns of mass production and disruptions in the supply chain that have impacted the economies of virtually every nation in the world. The pandemic also affected the non-small cell lung cancer diagnostic industry. The patient's fear of contracting the virus compels patients to stay home instead of undergoing diagnosis and treatment. During the COVID-19 pandemic, countries worldwide witnessed a large number of patients suffering from COVID-19 and post COVID-19 complications such as cardiovascular disease, diabetes and kidney problems. As the COVID-19 cases were rising, the healthcare system had shifted its focus in curbing the disease, thereby delaying diagnosis and treatment of other chronic conditions as cancer. Thus, a negative impact is expected on the non-small cell lung cancer diagnostics market due to the pandemic scenario As a result, the hospitals and clinics were filled up with COVID-19 patients and less preference was given to non-small cell lung cancer patients. Moreover, limited access to clinics, social distancing, the lockdown of the population, which results in a slow-down in patient flow and referrals, has also impacted the market growth. However, with the cases decreasing in number and increase in vaccination against COVID-19 across the globe, the market for non-small cell lung cancer diagnostics market may get a boost due to some relaxation in COVID-19 cases, which will result in increased demand for non-small cell lung cancer diagnosis with patients coming forward to clinics and hospitals for treatment. IMPACT ON DEMAND Various screening, diagnostic and surgical procedures were restricted and at hospitals and cancer treatment centers, which resulted in disruptions in the non-small cell lung cancer diagnostics market. However, even during the pandemic, the lung cancer cases were subsequent, which is expected to increase the demand for non-small cell lung cancer diagnostics market. For instance, · According to World Health Organization (WHO), in 2020, lung cancer accounted for 2,206 771 deaths among both sexes. The lung cancer statistics include both small cell lung cancer and non-small cell lung cancer. About 13% of all lung cancers are small cell lung cancer and 84% are non-small cell lung cancer. This proves an increase in the number of non-small cell lung cancer patients even during the COVID-19 pandemic. Moreover, according to the American Cancer Society, Inc., lung cancer patients are likely to get infected with coronavirus because of the changes in their immune system that control their body's defense systems. For instance, · According to a study published in PubMed, patients with lung cancer are at an increased risk of becoming infected with the virus and experience higher morbidity and mortality than the general population Thus, having cancer such as non-small cell lung cancer may also increase the risk of severe illness from COVID-19 as the cancer therapy treatment reduce the immune system of the body. . This has increased the demand for non-small cell lung cancer diagnostic tools, especially in cancer-dedicated hospitals and surgical centres, where all the patients of non-small cell lung cancer-related problems are treated. Thus, with the increased lung cancer cases, the demand for non-small cell lung cancer diagnostic will increase in the coming years. IMPACT ON SUPPLY CHAIN The supply chain was widely affected by the COVID-19 pandemic as acute restrictions and lockdowns produced many urgent situations in the early days of the pandemic, which needed immediate attention. The supply chain disruption has transformed many organizations' business environments, including the supply chain of non-small cell lung cancer diagnostics market. The supply chain disruption impacted the Asia-Pacific region initially, especially the demand from China due to challenges from restricted movement and quarantine period. For instance, · According to the FDA, 63 manufacturers representing 72 facilities in China that produce essential medical devices face obstacles in manufacturing medical devices and their supply, owing to citing workforce challenges and the necessary quarantine of workers. Moreover, closing borders of various countries is anticipated to diminish the supply chain business environment, as it may hamper export of the medical supplies To minimize supply chain crises, the FDA has been firmly monitoring the supply chain with the assumption that the COVID-19 outbreak may adversely impact the supply chain of medical products, including shortages of critical medical products in the U.S. or potential disruptions in supply chains. Many organizations and countries are looking forward to improving and diversified supply chain models in all aspects to manage such a crucial situation. A diversified supply chain model anticipated minimizing the export of medical products as well as increase end-to-end visibility. For instance, · The Brazilian government published a resolution eliminating import taxes on 141 medical products and hospital equipment · The European Commission made a decision for helping Member States affected by the pandemic to suspend customs duties and VAT on medical devices temporarily · Federal indirect tax body the Goods and Services Tax (GST) Council of India has decided to cut taxes on medical supplies IMPACT ON PRICE The coronavirus disease (COVID-19) pandemic does not significantly impact the global non-small cell lung cancer diagnostics market. But it is estimated that if COVID-19 continues to spread for a prolonged period, then the demand for non-small cell lung cancer diagnostic equipment and devices will highly upsurge for top importer countries. For therapies and the diagnostic United States solicit the huge number of medical devices, followed by China and Japan. For instance, · According to the General Administration of Customs (GAC), China's exports of medical machinery and devices increased 40.5 percent in 2020 compared to the previous year, reaching USD 18.138 billion · According to the World Trade Organisation, the U.S. imports and exports of medical goods increased by 16 %, reaching USD 1,139.00 billion in value Henceforth for diagnosis, dependency of these countries highly increases on other exporters and many countries solely depend on China and the U.S. for the non-small cell lung cancer diagnostic equipment. Consequently, this may lead to a rise in the overall non-small cell lung cancer diagnostic cost. This increase in the price of the non-small cell lung cancer diagnostic may hamper the market growth if it continues to be the same. Additionally, if the lockdown continues to stretch for a long period, then import of non-small cell lung cancer diagnostics market is estimated to get more restricted, which may further lead to a rise in the price of the these devices CONCLUSION It is estimated that the COVID-19 pandemic outbreak has significantly impacted the growth of non-small cell lung cancer diagnostics market as the rising cases of COVID-19 worldwide the healthcare system had shifted its focus in curbing the disease, thereby resulting in the delay of diagnosis and treatment of non-small cell lung cancer. Thus, a negative impact is expected on the non-small cell lung cancer diagnostics market due to the pandemic scenario. However, with the increase in lung cancer patients worldwide, the demand for non-small cell lung cancer diagnostics will increase in the coming years. Moreover, poor lifestyle, smoking, alcohol consumption, lack of physical activity and other factors will contribute to the incidence of chronic disease such as lung cancer, including non-small cell lung, which is anticipated to increase the global non-small cell lung cancer diagnostics market in the coming years.
Significant Impact of COVID-19 on Absorbable Heart Stent in Healthcare Industry
COVID-19 Impact on Absorbable Heart Stent in Healthcare Industry Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 or 2019-nCoV, is a human infectious disease caused by the coronavirus that causes severe acute respiratory syndrome. COVID-19 was declared a pandemic by the world health organization due to the rapid rise in human infection rates. The COVID-19 pandemic has influenced the whole planet with its major impacts on the economy and businesses across the globe. Though the emergence of the virus can be traced back to Asia, many European countries along with the U.S. have been struck massively by the pandemic. The virus has spread across all regions ranging from North America, Europe, Asia-Pacific, Middle East, and Africa up to South America. After the declaration of the pandemic, various countries announced the complete lockdown such as India, China, and other Asian countries to decrease its spread. According to the latest situation report by World Health Organization (WHO) stated 175 million cases of corona virus have been reported globally and 4 million patients are dead due to the coronavirus. On a slightly positive note, a total of 158 million people have recovered and a total of 2 million vaccine doses have been administered. On March 11, 2020, the World Health Organization declared the coronavirus COVID-19 pandemic. Coronavirus disease 2019 (COVID-19) is a worldwide pande0mic, and cardiovascular complications and arrhythmias in these patients are common. Cardiac monitoring is recommended for at-risk patients. The novel coronavirus pandemic has significantly impacted the timely delivery of surgical or stent treatment for patients with severe coronary vascular disease. This has created a large backlog of work and upstaging of disease with consequent increase in risk and cost of treatment and potential for worse long-term outcomes. As countries emerge from lockdown but with COVID-19 pandemic in society, precautions remain that restrict ‘normal’ practice. Stents are small, expandable tubes that treat narrowed arteries. Coronary artery stents are used to open the blockage of arteries or to expand the narrowing arteries, which helps to treat a heart attack, and reduce pain like chest pain. Absorbable Heart Stents are said to be “the fourth revolution” after balloon angioplasty, baremetal stents, and drug-eluting stents. As these provide mechanical support for a determined period and then disappear from the vessel, allowing its natural healing, and avoiding the risks associated with having a permanent metallic cage, such as stent thrombosis. The absorption of the stent could potentially lead to a recovery of the endothelial function of the vessel, making it responsive again to vasoactive agents. The potential benefits, including the decreased risk of stent thrombosis at long-term follow-up, one of the most feared complications of metallic stents, have led to absorbable stents, a field of growing interest in interventional cardiology. The increasing prevalence of geriatric population and adoption of sedentary lifestyle along with the rise of obesity in people are driving the absorbable heart stent market as coronary artery diseases require appropriate surgeries for 'their treatment’. But there is a negative impact of COVID-19 on the absorbable heart stent market due to massive disruption of supply chains, and financial fragility forced manufacturers to shut down their industries as absorbable stents require high financial inputs for manufacturing. For Instance, · According to the Center for Disease Control and Prevention (CDC), about 18.2 million US adults age 20 and older have CAD (about 6.7%), which has required appropriate treatment · According to the European Cardiovascular Disease Statistics 2017, each year, cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU) Moreover, COVID-19 has made it more challenging for the manufacturing companies to bridge the losses and attempt to fulfil the demands during these times. The COVID-19 has impacted the business of manufacturers, and other service providers that are involved in absorbable heart stent devices. IMPACT ON PRICE COVID-19 has forced the countries to impose lockdown and restrictions worldwide. This has affected many industries and economies. The total lockdown in various countries forbade the transportation of raw materials, and the business of service providers. So, manufacturing absorbable heart stent devices has become difficult, which directly impacted the prices largely. For instance, · In 2020, National Pharmaceutical Pricing Authority (NPPA) has been approved to hike the prices of absorbable heart stent on seeing the current scenario and making it easy for the manufacturers. IMPACT IN DEMAND The outbreak of the coronavirus has shown impacts on various markets around the world. It is the cause of lockdown and isolation, which ultimately has an impact on global economic activity. This is why the global epidemic has shrunk by 1.0% in the current year. Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. As heart patients are under suspection for higher exposure to COVID-19, demand for absorbable stents surges as companies are making efforts to provide help to healthcare systems to overcome the scarcity of stents while treating CAD. Absorbable stents are in high demand due to the high prevalence of interventional cardiology and peripheral vascular procedures amid the COVID-19 pandemic, which prevents the patient from staying in the hospital for long. The clinical observations suggest that a person with heart disease has been more prone to COVID-19, which lead to clinical complications. Therefore, the government of various countries laid guidelines for special care, and treatment for heart patients. This has surged the demand for absorbable stents among people for early treatment of CAD to prevent complications of COVID-19. For Instance, · According to an early bulletin released by the American College of Cardiology (ACC) on March 6, 2020, people who have underlying cardiovascular disease, have a higher mortality rate when it comes to COVID-19 (10.5 percent) than people who have an underlying chronic respiratory disease (6.3 percent) · According to the American Journal of the Medical Sciences, the COVID-19 mortality rate for people with pre-existing cardiovascular disease was between 10.5 and nearly 14 percent, and the number surged to between 35 percent and almost 87 percent for people who had underlying coronary artery disease IMPACT ON SUPPLY CHAIN The COVID-19 outbreak has disrupted the supply chains for absorbable heart stents globally. The sudden outbreak of COVID-19 and its subsequent impact on restrictions on trade and development of goods has resulted in a shutdown of vast portions of the global economy, resulting in disrupted supply chains due to transportation cessation, which affected the manufacturing unit largely. Companies in the arterial stents market are helping healthcare systems to stock inventory and medical devices in order to avoid supply shocks amidst the COVID-19 pandemic. For instance, · According to FDA, there have been reported shortages of medical devices and equipment amid COVID-19 due to disruption of supply and service providers · According to Springer, 2020, many companies experienced dramatic exposure to supply chain disruptions during the pandemic and the subsequent lockdowns (Strange 2020) due to their reliance on offshore supplies STRATEGIC INITIATIVES FOR MANUFACTURERS A large pool of the population affected by this COVID-19 virus, and its spread is expanding across the world in the last few months. To deal with the COVID-19 outbreak challenges, many market players are creating new strategies. The key players engaged in providing products such as Medtronic, Boston Scientific Corporation, Abbott, Cook Group, Angiomed GmbH & Co. Medizintechnik KG face challenges to keep the growth during coronavirus and to maintain the demand and supply chain with proper protection of the employees. For instance, · Medtronic focused on providing special protection and care to its employees. Its manufacturing and distribution facilities are routinely cleaned and sanitized, employees are utilizing personal protective equipment (PPE) and social distancing, including staggered breaks to reduce crowds in common areas, and additional screening and access protocols have been implemented. · Medtronic increased contributions to its Employee Emergency Assistance Fund, which is providing need-based financial grants to employees who are experiencing economic impact due to the COVID-19 pandemic, including childcare reimbursement. · Boston Scientific Corporation is providing extra precautions, including increased cleaning measures, social distancing protocols, and the use of face coverings for employees who work onsite, along with personal protective equipment (PPE) for employees in the workplace ensuring business continuity. CONCLUSION The COVID-19 has impacted the market positively. To summarize, the prices for this market has increased as manufacturing requires raw materials which have been disrupted amid COVID-19. The demand for absorbable heart stent market has been increasing due to the prevalence of geriatric population and adoption of sedentary lifestyle which leads to various coronary vascular diseases, but the supply chain and service providers are unable to satisfy the needs, and thus, have impacted largely. However, manufacturers, service providers, and the government are making new guidelines to work safely in the workplace in the new normal and combat the gap between demand and supply. Overall, various measures have been taken by the market players to improve their business and the quality of their services.
[September-2021]Braindump2go New AZ-104 PDF and VCE Dumps Free Share(Q480-Q501)
QUESTION 480 Note: The question is included in a number of questions that depicts the identical set-up. However, every question has a distinctive result. Establish if the solution satisfies the requirements. Your company's Azure subscription includes two Azure networks named VirtualNetworkA and VirtualNetworkB. VirtualNetworkA includes a VPN gateway that is configured to make use of static routing. Also, a site-to-site VPN connection exists between your company's on-premises network and VirtualNetworkA. You have configured a point-to-site VPN connection to VirtualNetworkA from a workstation running Windows 10. After configuring virtual network peering between VirtualNetworkA and VirtualNetworkB, you confirm that you are able to access VirtualNetworkB from the company's on-premises network. However, you find that you cannot establish a connection to VirtualNetworkB from the Windows 10 workstation. You have to make sure that a connection to VirtualNetworkB can be established from the Windows 10 workstation. Solution: You choose the Allow gateway transit setting on VirtualNetworkB. Does the solution meet the goal? A.Yes B.No Answer: B QUESTION 481 Note: The question is included in a number of questions that depicts the identical set-up. However, every question has a distinctive result. Establish if the solution satisfies the requirements. Your company's Azure subscription includes two Azure networks named VirtualNetworkA and VirtualNetworkB. VirtualNetworkA includes a VPN gateway that is configured to make use of static routing. Also, a site-to-site VPN connection exists between your company's on-premises network and VirtualNetworkA. You have configured a point-to-site VPN connection to VirtualNetworkA from a workstation running Windows 10. After configuring virtual network peering between VirtualNetworkA and VirtualNetworkB, you confirm that you are able to access VirtualNetworkB from the company's on-premises network. However, you find that you cannot establish a connection to VirtualNetworkB from the Windows 10 workstation. You have to make sure that a connection to VirtualNetworkB can be established from the Windows 10 workstation. Solution: You download and re-install the VPN client configuration package on the Windows 10 workstation. Does the solution meet the goal? A.Yes B.No Answer: A QUESTION 482 Your company has virtual machines (VMs) hosted in Microsoft Azure. The VMs are located in a single Azure virtual network named VNet1. The company has users that work remotely. The remote workers require access to the VMs on VNet1. You need to provide access for the remote workers. What should you do? A.Configure a Site-to-Site (S2S) VPN. B.Configure a VNet-toVNet VPN. C.Configure a Point-to-Site (P2S) VPN. D.Configure DirectAccess on a Windows Server 2012 server VM. E.Configure a Multi-Site VPN Answer: C QUESTION 483 Note: The question is included in a number of questions that depicts the identical set-up. However, every question has a distinctive result. Establish if the solution satisfies the requirements. Your company has a Microsoft SQL Server Always On availability group configured on their Azure virtual machines (VMs). You need to configure an Azure internal load balancer as a listener for the availability group. Solution: You create an HTTP health probe on port 1433. Does the solution meet the goal? A.Yes B.No Answer: B QUESTION 484 Note: The question is included in a number of questions that depicts the identical set-up. However, every question has a distinctive result. Establish if the solution satisfies the requirements. Your company has a Microsoft SQL Server Always On availability group configured on their Azure virtual machines (VMs). You need to configure an Azure internal load balancer as a listener for the availability group. Solution: You set Session persistence to Client IP. Does the solution meet the goal? A.Yes B.No Answer: B QUESTION 485 Note: The question is included in a number of questions that depicts the identical set-up. However, every question has a distinctive result. Establish if the solution satisfies the requirements. Your company has a Microsoft SQL Server Always On availability group configured on their Azure virtual machines (VMs). You need to configure an Azure internal load balancer as a listener for the availability group. Solution: You enable Floating IP. Does the solution meet the goal? A.Yes B.No Answer: A QUESTION 486 Your company has two on-premises servers named SRV01 and SRV02. Developers have created an application that runs on SRV01. The application calls a service on SRV02 by IP address. You plan to migrate the application on Azure virtual machines (VMs). You have configured two VMs on a single subnet in an Azure virtual network. You need to configure the two VMs with static internal IP addresses. What should you do? A.Run the New-AzureRMVMConfig PowerShell cmdlet. B.Run the Set-AzureSubnet PowerShell cmdlet. C.Modify the VM properties in the Azure Management Portal. D.Modify the IP properties in Windows Network and Sharing Center. E.Run the Set-AzureStaticVNetIP PowerShell cmdlet. Answer: E Explanation: Specify a static internal IP for a previously created VM If you want to set a static IP address for a VM that you previously created, you can do so by using the following cmdlets. If you already set an IP address for the VM and you want to change it to a different IP address, you'll need to remove the existing static IP address before running these cmdlets. See the instructions below to remove a static IP. For this procedure, you'll use the Update-AzureVM cmdlet. The Update-AzureVM cmdlet restarts the VM as part of the update process. The DIP that you specify will be assigned after the VM restarts. In this example, we set the IP address for VM2, which is located in cloud service StaticDemo. Get-AzureVM -ServiceName StaticDemo -Name VM2 | Set-AzureStaticVNetIP -IPAddress 192.168.4.7 | Update-AzureVM QUESTION 487 Your company has an Azure Active Directory (Azure AD) subscription. You need to deploy five virtual machines (VMs) to your company's virtual network subnet. The VMs will each have both a public and private IP address. Inbound and outbound security rules for all of these virtual machines must be identical. Which of the following is the least amount of network interfaces needed for this configuration? A.5 B.10 C.20 D.40 Answer: A QUESTION 488 Your company has an Azure Active Directory (Azure AD) subscription. You need to deploy five virtual machines (VMs) to your company's virtual network subnet. The VMs will each have both a public and private IP address. Inbound and outbound security rules for all of these virtual machines must be identical. Which of the following is the least amount of security groups needed for this configuration? A.4 B.3 C.2 D.1 Answer: D QUESTION 489 Your company's Azure subscription includes Azure virtual machines (VMs) that run Windows Server 2016. One of the VMs is backed up every day using Azure Backup Instant Restore. When the VM becomes infected with data encrypting ransomware, you decide to recover the VM's files. Which of the following is TRUE in this scenario? A.You can only recover the files to the infected VM. B.You can recover the files to any VM within the company's subscription. C.You can only recover the files to a new VM. D.You will not be able to recover the files. Answer: A QUESTION 490 Your company's Azure subscription includes Azure virtual machines (VMs) that run Windows Server 2016. One of the VMs is backed up every day using Azure Backup Instant Restore. When the VM becomes infected with data encrypting ransomware, you are required to restore the VM. Which of the following actions should you take? A.You should restore the VM after deleting the infected VM. B.You should restore the VM to any VM within the company's subscription. C.You should restore the VM to a new Azure VM. D.You should restore the VM to an on-premise Windows device. Answer: B QUESTION 491 You administer a solution in Azure that is currently having performance issues. You need to find the cause of the performance issues pertaining to metrics on the Azure infrastructure. Which of the following is the tool you should use? A.Azure Traffic Analytics B.Azure Monitor C.Azure Activity Log D.Azure Advisor Answer: B QUESTION 492 Your company has an Azure subscription that includes a Recovery Services vault. You want to use Azure Backup to schedule a backup of your company's virtual machines (VMs) to the Recovery Services vault. Which of the following VMs can you back up? Choose all that apply. A.VMs that run Windows 10. B.VMs that run Windows Server 2012 or higher. C.VMs that have NOT been shut down. D.VMs that run Debian 8.2+. E.VMs that have been shut down. Answer: ABCDE QUESTION 493 You have a registered DNS domain named contoso.com. You create a public Azure DNS zone named contoso.com. You need to ensure that records created in the contoso.com zone are resolvable from the internet. What should you do? A.Create NS records in contoso.com. B.Modify the SOA record in the DNS domain registrar. C.Create the SOA record in contoso.com. D.Modify the NS records in the DNS domain registrar. Answer: D QUESTION 494 You have an Azure Storage account named storage1 that contains a blob container named container1. You need to prevent new content added to container1 from being modified for one year. What should you configure? A.the access tier B.an access policy C.the Access control (IAM) settings D.the access level Answer: B QUESTION 495 You have an Azure subscription. In the Azure portal, you plan to create a storage account named storage1 that will have the following settings: - Performance: Standard - Replication: Zone-redundant storage (ZRS) - Access tier (default): Cool - Hierarchical namespace: Disabled You need to ensure that you can set Account kind for storage1 to BlockBlobStorage. Which setting should you modify first? A.Performance B.Replication C.Access tier (default) D.Hierarchical namespace Answer: A QUESTION 496 Note: This question is part of a series of questions that present the same scenario. Each question in the series contains a unique solution that might meet the stated goals. Some question sets might have more than one correct solution, while others might not have a correct solution. After you answer a question in this section, you will NOT be able to return to it. As a result, these questions will not appear in the review screen. You have an Azure virtual machine named VM1 that runs Windows Server 2016. You need to create an alert in Azure when more than two error events are logged to the System event log on VM1 within an hour. Solution: You create an Azure Log Analytics workspace and configure the Agent configuration settings. You install the Microsoft Monitoring Agent on VM1. You create an alert in Azure Monitor and specify the Log Analytics workspace as the source. Does this meet the goal? A.Yes B.No Answer: A QUESTION 497 Note: This question is part of a series of questions that present the same scenario. Each question in the series contains a unique solution that might meet the stated goals. Some question sets might have more than one correct solution, while others might not have a correct solution. After you answer a question in this section, you will NOT be able to return to it. As a result, these questions will not appear in the review screen. You manage a virtual network named VNet1 that is hosted in the West US Azure region. VNet1 hosts two virtual machines named VM1 and VM2 that run Windows Server. You need to inspect all the network traffic from VM1 to VM2 for a period of three hours. Solution: From Azure Monitor, you create a metric on Network In and Network Out. Does this meet the goal? A.Yes B.No Answer: B QUESTION 498 Note: This question is part of a series of questions that present the same scenario. Each question in the series contains a unique solution that might meet the stated goals. Some question sets might have more than one correct solution, while others might not have a correct solution. After you answer a question in this section, you will NOT be able to return to it. As a result, these questions will not appear in the review screen. You have an app named App1 that is installed on two Azure virtual machines named VM1 and VM2. Connections to App1 are managed by using an Azure Load Balancer. The effective network security configurations for VM2 are shown in the following exhibit. You discover that connections to App1 from 131.107.100.50 over TCP port 443 fail. You verify that the Load Balancer rules are configured correctly. You need to ensure that connections to App1 can be established successfully from 131.107.100.50 over TCP port 443. Solution: You create an inbound security rule that denies all traffic from the 131.107.100.50 source and has a priority of 64999. Does this meet the goal? A.Yes B.No Answer: B QUESTION 499 You have a virtual network named VNet1 as shown in the exhibit. (Click the Exhibit tab.) No devices are connected to VNet1. You plan to peer VNet1 to another virtual network named VNet2. VNet2 has an address space of 10.2.0.0/16. You need to create the peering. What should you do first? A.Modify the address space of VNet1. B.Add a gateway subnet to VNet1. C.Create a subnet on VNet1 and VNet2. D.Configure a service endpoint on VNet2. Answer: A QUESTION 500 You have the Azure virtual machines shown in the following table. VNET1 is linked to a private DNS zone named contoso.com that contains the records shown in the following table. You need to ping VM2 from VM1. Which DNS names can you use to ping VM2? A.comp2.contoso.com and comp4.contoso.com only B.comp1.contoso.com, comp2.contoso.com, comp3.contoso.com, and comp4.contoso.com C.comp2.contoso.com only D.comp1.contoso.com and comp2.contoso.com only E.comp1.contoso.com, comp2.contoso.com, and comp4.contoso.com only Answer: B QUESTION 501 Note: This question is part of a series of questions that present the same scenario. Each question in the series contains a unique solution that might meet the stated goals. Some question sets might have more than one correct solution, while others might not have a correct solution. After you answer a question in this section, you will NOT be able to return to it. As a result, these questions will not appear in the review screen. You have a computer named Computer1 that has a point-to-site VPN connection to an Azure virtual network named VNet1. The point-to-site connection uses a self-signed certificate. From Azure, you download and install the VPN client configuration package on a computer named Computer2. You need to ensure that you can establish a point-to-site VPN connection to VNet1 from Computer2. Solution: On Computer2, you set the Startup type for the IPSec Policy Agent service to Automatic. Does this meet the goal? A.Yes B.No Answer: B 2021 Latest Braindump2go AZ-104 PDF and AZ-104 VCE Dumps Free Share: https://drive.google.com/drive/folders/1UgWYSJj0uEU0eN4Uz8jnKDmXdqJJkSzZ?usp=sharing
How COVID-19 Impacted on Nutraceutical Packaging in Healthcare Industry ?
COVID-19 Impact on Nutraceutical Packaging in Healthcare Industry The COVID-19 pandemic has impacted the food and beverages industry including the nutraceutical market by up surging in their consumption globally. Each and every segment of nutraceutical industry has been impacted either positively or negatively due to the COVID-19 pandemic. The Nutraceutical packaging market is subjected to have the positive impacts due to the sudden outbreak of COVID- 19. This is mainly due to the consumer awareness about the importance of consuming the nutraceuticals in order to boost their immunity to fight the pandemic period. The demand for the nutraceuticals has been increasing across the globe due to the changing lifestyle of the health conscious consumers. This increase in the demand for the nutraceuticals have positively affected on the nutraceutical packaging market. AFTERMATH OF COVID-19 AND GOVERNMENTS INITIATIVE TO BOOST THE GROWTH OF THE MARKET The aftermath of the COVID- 19 has a very positive impact on the market of the nutraceutical packaging across the globe. As the consumers are more incline to buy health and wellness products such as nutraceutical products which further increased the sales and revenue of the market players. The post pandemic period people are more concerned towards the product’s safety and shelf life which further drive the demand for advanced and innovative packaging materials for nutraceuticals. Also, with the growing awareness and growing social media nutritional trends influencing population all around the world will increase drive the demand for nutraceutical which will further boost the growth of global market. Many governments have taken initiatives for the nutraceutical packaging as they have been focusing on ways to improve the consumer’s health and wellness. The government initiatives to support industries in order to manufacture innovative packaging products will boost the growth of the market. For example, · European Union (EU)- funded project NanoPack aims to develop packaging solutions that increase product life after packaging by using novel anti-microbial surface application on the food packaging product surface. The Nanopack antibacterial film extends the shelf life of the product by two days. This two day increase in shelf life increase product stability by 40%. Therefore, such initiatives taken up by the governments which aim to help the manufacturers to manufacture safe products for the nutraceutical packaging will propel the growth of the market. STRATEGIC DECISIONS OF MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE To deal with the COVID-19 outbreak challenges many nutraceutical packaging market players are creating new strategies. It is predicted that these strategies are providing high chances to escalate up company revenue and its growth in the forecast period. Similarly, growing opportunities in innovative packaging solutions is attracting a larger consumer base for the nutraceutical packaged products. Increase in the demand for the nutraceuticals has made companies to launch the new products in spite of the COVID- 19 challenges and to gain a larger market share. Despite of the COVID – 19 pandemic outbreak, the manufacturers have been creating new opportunities by themselves by participating in exhibitions in order to spread the awareness about the nutraceuticals and their nutritional benefits which helps in boosting the immunity of the consumers. For instance, · In 2021, MJS packaging announced that they will exhibit for the first time since the start of COVID- 19 pandemic at the 2021 Cannabusiness international market place Michigan summit and expo in Michigan. Therefore, such product launches, exhibition of the products at the expos and vents in order to increase their consumer base are the strategic decisions which are taken up the market players to gain larger market share. PRICE IMPACT The COVID-19 had a terrible impact on the global economy. Many establishments have to remain shut while others scale down their operations or put on hold expansion plans as they survive the unprecedented crisis. The other impact of the COVID-19 pandemic outbreak is the delay or fluctuation of raw material supply for nutraceutical packaging manufacturing. This fluctuation has resulted in increase in price of raw material, which has impacted the prices of nutraceutical packaging products. IMPACT ON DEMAND There is a rapid increase in demand for the nutraceuticals increasing popularity for the nutraceutical packaging as well. Demand for the increased shelf life of food products across the globe is expected to increase the growth of the market in the COVID-19 period as well. There is an increasing consciousness about health and weight management is playing a crucial role in the demand for the global nutraceutical packaging market. On an average, the consumers have increased have increased their monthly spending on vitamins, minerals and supplements products by 10-15% since the COVID- 19 began. The increase in the awareness among the consumers about the consumption of the nutraceuticals is that they can build the immunity that is highly required in the COVID- 19 pandemic period has positively affected on the nutraceutical packaging as well. With the rise in the consumption of the nutraceutical in order to maintain the good health and fitness, the demand for the nutraceutical packaging also increased. Therefore, there has been a constant increase in the demand for the nutraceuticals which positively affected on the nutraceuticals packaging market as the packaging of the vitamins, minerals and other dietary supplements is the major factor that attracted the attention of the consumers. IMPACT ON SUPPLY CHAIN During the pandemic situation, the supply chain was majorly disrupted due to a lack of resources and transportation. Also, the governments across the world have implemented various restrictions and lockdowns to prevent the spread of the disease. In the same way, many governments have restricted the movement of goods across the countries and the entire supply chain was distorted. Owing to the disrupted supply chain, the transportation of raw materials has been interrupted and the production of nutraceutical packaging products was halted. Similarly, the manufacturers aren’t able to visit the customers such as nutraceutical companies to provide them with the packaging materials due to the implementation of lockdowns across the various parts of the world. Thus the demand for nutraceutical products has been tremendously increasing whereas the packaging materials production has been disrupted. As a result, the COVID- 19 pandemic has negatively impacted on the supply chain of the nutraceuticals packaging market. CONCLUSION COVID- 19 pandemic has taken a toll on the population and economy. A collaborative effort on governments, public health departments and hospital fraternity to fight corona virus has led to the economic slowdowns, lockdowns and extreme public safety measures. Due to the increasing health conscious ness among the consumers, the demand for the nutraceuticals has been increasing constantly in the COVID – 19 pandemic periods. This is mainly because of precautionary measures which are followed by the consumers for the COVID-19 which in involves the intake of nutraceuticals. However, the supply chain has disrupted during the outbreak scenario because the demand is more for these products. As unlocking of the lockdown being started in various regions of the world, it is expected that the supply chain became normalized for the market.
[September-2021]Braindump2go New MD-100 PDF and VCE Dumps Free Share(Q281-Q294)
QUESTION 281 Your network contains an Active Directory domain. All users have been issued with new computers that run Windows 10 Enterprise. All users have Microsoft 365 E3 licenses. A user named Mia Hamm has an Active Directory user account named MHamm and a computer named Computer1. Mia Hamm reports that Computer1 is not activated. You need to ensure that Mia Hamm can activate Computer1. What should you do? A.Assign a Windows 10 Enterprise license to MHamm, and then activate Computer1. B.From the Microsoft Deployment Toolkit (MDT), redeploy Computer1. C.From System Properties on Computer1, enter a Volume License Key, and then activate Computer1. D.Instruct Mia Hamm to perform a local AutoPilot Reset on Computer1, and then activate Computer1. Answer: D QUESTION 282 Your network contains an Active Directory domain that is synced to a Microsoft Azure Active Directory (Azure AD) tenant. The company plans to purchase computers preinstalled with Windows 10 Pro for all users. The company the following requirements: - The new computers must be upgraded to Windows 10 Enterprise automatically. - The new computers must be joined to Azure AD automatically when the user starts the new computers for the first time. - The users must not be required to accept the End User License Agreement (EULA). You need to deploy the new computers. What should you do? A.Make use of the wipe and load refresh deployment method. B.Perform in-place upgrade on the new computers. C.Provide provisioning packages for the new computers. D.Make use of Windows Autopilot. Answer: D QUESTION 283 Your company is not connected to the internet. The company purchases several new computers with Windows 10 Pro for its users. None of the new computers are activated. You need to activate the computers without connecting the network to the Internet. What should you do? A.Make use of the Volume Activation Management Tool (VAMT). B.Make use of the Key Management Service (KMS). C.Make use of the Windows Process Activation Service. D.Run the Get-WmiObject -query cmdlet. Answer: B QUESTION 284 Your network contains an Active Directory domain. All users have been issued with computers that run Windows 8.1. A user named Mia Hamm has a computer named Computer1. You upgrade Computer1 to Windows 10 by performing a clean installation of Windows 10 without formatting the drives. You need to migrate the settings for Mia Hamm from Windows 8.1 to Windows 10. Which two actions should you perform? NOTE: Each correct selection is worth one point. A.Run scanstate.exe and specify the C:\Users folder B.Run loadstate.exe and specify the C:\Windows.old folder C.Run usmultils.exe and specify the C:\Users folder D.Run scanstate.exe and specify the C:\Windows.old folder E.Run loadstate.exe and specify the C:\Users folder F.Run usmultils.exe and specify the C:\Windows.old folder Answer: DE QUESTION 285 You have a computer named Computer1 that runs Windows 10. You deploy an application named Application1 to Computer1. You need to assign credentials to Application1. You need to meet the following requirements: Ensure that the credentials for Application1 cannot be used by any user to log on to Computer1. Ensure that the principle of least privilege is maintained. What should you do? A.Configure Application1 to sign in as the Local System account and select the Allow service to interact with desktop check box. B.Create a user account for Application1 and assign that user account the Deny log on locally user right C.Create a user account for Application1 and assign that user account the Deny log on as a service user right D.Configure Application1 to sign in as the Local Service account and select the Allow service to interact with desktop check box. Answer: B QUESTION 286 Your network contains an Active Directory domain that is synced to a Microsoft Azure Active Directory (Azure AD) tenant. All users have been issued with laptop computers as well as desktop computers that run Windows 10 Enterprise. All users have Microsoft 365 E3 licenses. A user named Mia Hamm informs you that she must perform a BitLocker recovery on her laptop but she does not have her BitLocker recovery key. You need to ensure that Mia Hamm can perform a BitLocker recovery on her laptop. What should you do? A.Instruct Mia Hamm to log on to her desktop computer and run the repair-bde.exe command. B.Instruct Mia Hamm to use the BitLocker Recovery Password Viewer to view the computer object of the laptop. C.Instruct Mia Hamm to log on to her desktop computer and go to https:// account.activedirectory.windowsazure.com and view the user account profile. D.Instruct Mia Hamm to run the Enable-BitLocker cmdlet on her laptop. Answer: C QUESTION 287 Your company has an on-premises network that contains an Active Directory domain. The domain is synced to Microsoft Azure Active Directory (Azure AD). All computers in the domain run Windows 10 Enterprise. You have a computer named Computer1 that has a folder named Folder1. You must provide users in group named Group1 with the ability to view the list of files in Folder1. Your solution must ensure that the principle of least privilege is maintained. What should you do? A.Assign the Full control permissions for the Folder1 folder to Group1. B.Assign the Read permissions for the Folder1 folder to Group1. C.Assign the List folder permissions for the Folder1 folder to Group1. D.Assign the Take ownership permissions for the Folder1 folder to Group1. Answer: C QUESTION 288 You have a computer named Computer1 that runs Windows 10. Computer1 has a folder named C:\Folder1. You need to meet the following requirements: - Log users that access C:\Folder1. - Log users that modify and delete files in C:\Folder1. Which two actions should you perform? A.From the properties of C:\Folder1, configure the Auditing settings. B.From the properties of C:\Folder1, select the Encryption contents to secure data option. C.From the Audit Policy in the local Group Policy, configure Audit directory service access. D.From the Audit Policy in the local Group Policy, you configure Audit object access. E.From the Audit Policy in the local Group Policy, you configure Audit system events. Answer: AD QUESTION 289 Your company has a computer named Computer1 that runs Windows 10. Computer1 is used to provide guests with access to the Internet. Computer1 is a member of a workgroup. You want to configure Computer1 to use a user account sign in automatically when the the computer is started. The user must not be prompted for a user name and password. What should you do? A.Configure Group Policy preferences. B.Run the BCDBoot command. C.Edit the Registry. D.Run the MSConfig command. Answer: C QUESTION 290 Your network contains an Active Directory domain. The domain contains computers that run Windows 10. You must ensure that Windows BitLocker Drive Encryption is enabled on all client computers, even though a Trusted Platform Module (TPM) chip is installed in only some of them. You need to accomplish this goal by using one Group Policy object (GPO). What should you do? A.Enable the Allow enhanced PINs for startup policy setting, and select the Allow BitLocker without a compatible TPM check box. B.Enable the Enable use of BitLocker authentication requiring preboot keyboard input on slates policy setting, and select the Allow BitLocker without a compatible TPM check box. C.Enable the Require additional authentication at startup policy setting, and select the Allow BitLocker without a compatible TPM check box. D.Enable the Control use of BitLocker on removable drives policy setting, and select the Allow BitLocker without a compatible TPM check box. Answer: C QUESTION 291 You have a computer named Computer1. Computer1 runs Windows 10 Pro. Computer1 is experiencing connectivity issues. You need to view the IP addresses of any remote computer that Computer1 has an active TCP connection to. Should you do? A.In Windows Administrative Tools, open Performance Monitor. B.In the Control Panel, open Network and Internet. Then select Network and Sharing Center. C.In Windows Administrative Tools, open Resource Monitor. D.In the Setting app, open Update and Security. Then open Windows Security and select Firewall and Network protection. Answer: C QUESTION 292 You have a computer named Computer1. Computer1 runs Windows 10 Pro. You attempt to start Computer1 but you receive the following error message: Bootmgr is missing. You need to be able to start Computer1. What should you do? A.Start the computer in recovery mode and run the bootrec /rebuildbcd command. B.Start the computer in recovery mode and run the diskpart /repair command. C.Start the computer in recovery mode and run the bcdboot /s command. D.Start the computer in recovery mode and run the bootcfg /debug command. Answer: A QUESTION 293 Your company has several mobile devices that run Windows 10. You need configure the mobile devices to meet the following requirements: Windows updates may only be download when mobile devices are connect to Wi-Fi. Access to email and the Internet must be possible at all times. What should you do? A.Open the Setting app and select Update & Security. Then select and configure Change active hours. B.Open the Setting app and select Network & Internet. Then select Change connection properties, and set the Metered connection option for cellular network connections to On. C.Open the Setting app and select Network & Internet. Then select Data Usage and set a data limit. D.Open the Setting app and select Update & Security. Then select and configure Delivery Optimization. Answer: B QUESTION 294 Note: This question is part of a series of questions that present the same scenario. Each question in the series contains a unique solution that might meet the stated goals. Some question sets might have more than one correct solution, while others might not have a correct solution. After you answer a question in this section, you will NOT be able to return to it. As a result, these questions will not appear in the review screen. Your company has an on-premises network that contains an Active Directory domain. The domain is synced to Microsoft Azure Active Directory (Azure AD). All computers in the domain run Windows 10 Enterprise. You have a computer named Computer1 that has a folder named C:\Folder1. You want to use File History to protect C:\Folder1. Solution: You enable File History on Computer1. You then enable archiving for Folder1. Does this meet the goal? A.Yes B.No Answer: B 2021 Latest Braindump2go MD-100 PDF and MD-100 VCE Dumps Free Share: https://drive.google.com/drive/folders/1JUVP5MWzD2NVdlAoSATpQirlejY0T0r_?usp=sharing
Significant COVID-19 Impact on Footwear Sole Material in Chemical and Material Industry
COVID-19 Impact on Footwear Sole Material in Chemical and Material Industry INTRODUCTION Footwear designs have continuously upgraded with the advance techniques for improvement of comfort and performance of the shoes in daily routine or specialized sports applications. In footwear, the sole of footwear is very important part as sole have to face the external environment. The sole of footwear helps to protect the feet from injury during work or performing physical activities. In 1800 wood was used for manufacturing of sole. As the time passed the demand of more rubber sole shoe was increased as it was cost effective and also more comfortable in wearing for longer duration. Sandals of leather were also introduced in 1900 which was accepted globally. The leather straps were joined with the rubber sole to manufacture the footwear. The footwear of leather and wood were heavy which cannot be weared for longer duration. So light weight material was started to be used for the manufacturing of sole of footwear. In 19th century, outsole of footwear has been changed in materials. Leather has been the traditional soling material, after 1980 only about 5% of shoes have leather soles. Now, most of soles are made of rubber or plastics, which are classed as synthetics rubber. Polyurethane is one of them that become most popular soling material for footwear. Sole material is the kind of material which is used for the manufacturing of different kinds of sole according to the application of shoe. Sole material are the kind of material which are resistant to putrefaction and enzymatic destruction and after repeated wetting-drying cycles returns back to its former soft characteristics due which material is used in the manufacturing of sole for footwear. Shoe soles are made from a variety of different materials which includes rubber, leather, polyurethane and other bio-compounds. Sole material is also used for manufacturing of inner sole which is softer than the outsole. Sole of a shoe is also known as outsole which is bottom part of the shoe. More of the times outsole comes in direct contact with the ground. Footwear sole is made up of soling materials such as: Polyurethane Polyurethane is a type of polymer which is composed of organic units which are joined by carbamate links. Polyurethanes are kind of thermosetting polymers which do not melt when heated on high temperature. Polyurethane is of different types which are methylene diisocyanate (MDI), toluene diisocyanate (TDI) and polyols. Rubber Rubber is kind of elastic substance which is obtained from exudations of certain tropical plants which is natural rubber. Rubber products are also derived from petroleum and natural gas which is called as synthetic rubber. Bio-Compounds Bio-compounds are materials which are made of several cells and other structures of organisms are known as bio chemicals compounds. In bio-compounds carbon compounds are important which make the material light weight. Several materials are being used in the production of footwear sole which can provide high comfort and light weight shoe. Different types of shoes are being used for different application due to which different materials are being used in the production of footwear sole. Polyurethanes as a soling material is comprise of almost limitless chemical formulation combinations which give designers and manufacturers freedom to create innovative designs according to the application of the shoe. The soft inner sole is more in demand among women fashionable footwear and daily wears and also for kids due to lightweight and super soft sole material which is more used in the footwear. COVID-19 IMPACT ON FOOTWEAR SOLE MATERIAL MARKET Corona virus was started from the China country and now has reached to every corner of the word. The COVID-19 has larger impact on different industries due to which the growth of the business and world is recovering in very steady pace. The pandemic have hit the economy very hard world wide as the lockdown was imposed in all the regions which have made the situation challenging for all sector for growth and also the developing actives will be done in the stager manner. No sector was immune from the effect of the COVID-19 as all the manufactures of the footwear sole material in the regions have faced the ups and down in the business due to the COVID-19 situation and unable to forecast the demand of the footwear in the market. The demand for the footwear sole material has fallen in the industries due to the lower production of the footwear in the global market. The export and import of the footwear sole material in different countries have fallen down due to the pandemic situation created by COVID-19. The big brands or manufactures are producing at 25%-30% of their full capacity as demand of the footwear has fallen in the market. Government has imposed the lockdown rules in the entire region due to which people are setting at their home. The demand for the light weight sole material in the footwear have fallen down in pandemic no physical activities were going on which lower the demand for sport shoes in different games and physical activities. Different types of footwear sole are used in different type of footwear functionality. Due to lockdown in several manufactures activities were on halt, the demand of footwear has fallen down in the industries due to which the demand for footwear sole materials have decline. The cascading effect of the spread of the corona virus can also be seen on the foot wear industry. Footwear industry have also have to face the pandemic situation which created by the COVID-19. The production in the footwear industry has been on halt due to the lock down and shortage of the labor in the factory. The virus is taking a massive toll in the economic front, shutting down businesses, curbing international travel and impacting production lines of major global businesses. On evaluating footwear industry in the countries, the major brands have shut down their stores, and some of them have also delayed their new collection release which has lowered the demand for the footwear sole material in the market. FIGURE 1 NEW PRODUCT INTRODUCTION RATE (2019 –2020) From the above diagram we can interpret that the introduction of the new footwear models in 2020 was fallen down as in 2019 introduction of athletics shoes and sneakers was 11.00% which fall to 4.15% in 2020. In 2019 introduction of boots was 3.00% which fall to 5.00% in 2020. In 2019 introduction of heeled shoes was 12.00% which fall to 5.00% in 2020. With the decline in the introduction of new products in the market will have negative impact on the demand for footwear sole material in the market. IMPACT ON RELATED INDUSTRY OF FOOTWEAR SOLE MATERIAL IMPACT ON FOOTWEAR INDUSTRY According to experts of World Footwear, global footwear consumption is expected to fall by 22.5% in pandemic year. In Europe, demand of footwear declined by 27%, in North America demand of footwear is declined by 21%, and in Asia-Pacific demand of footwear is declined by 20%. The revenue of the foot wear industry has fallen down by 10%-15% in the pandemic situation as the import and export of the footwear have been declined. The demand of the footwear on all distribution channels have declined globally due to which manufactures have to face the challenge of the stock clearance. Footwear companies such as Adidas and Puma are also experiencing major effects due to the coronavirus headwinds. Most of the branded stores have been closed in the virus-driven countries. The big brands have lost the sales of USD 50 million to USD 60 million due to the outbreak. Other luxury labels are predicting serious blows to their sales too. With the falling sales of the footwear in the market have lower the demand of different footwear sole material which have impacted the global footwear sole material market. STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE Manufacturers of footwear sole material market have to face many difficulties due to halt in the industries which leads to low demand of footwear for all end-user segment which resulted into low demand of footwear sole material in market. The demand of footwear sole material is more in athletic shoes and also in daily wear flip-flops in the end-user segment which helped the manufacturers to earn profits from the stock as the demand for the light weight flip flops and sandals which people wear on daily basis have increased on larger extent. Manufacturers have also taken strategic decision to cover the losses which occurred due to COVID-19. Several OEMs and manufacturing industry have collaborated together and started production. In addition, fulfilling the demand of footwear sole material in the different countries manufactures are helping each other financially in business. IMPACT ON THE RAW MATERIAL PRICE Synthetic rubber is used in the manufacturing of the sole of the footwear. With decline in the demand of the footwear which resulted in decline in synthetic rubber footwear sole material during the COVID-19. Synthetic rubber footwear sole material is more used in the footwear industry as to fold and cut due to the property of flexibility which increases its demand in the footwear industry. Due to COVID–19, prices of footwear sole material are adversely affected as the downfall in demand of footwear in various industries. FIGURE 2 PRICE OF SYNTHETIC RUBBER (JANUARY 2020 –JULY 2020)(USD) From the above diagram we can infer that the price of the synthetic rubber is falling on constant rate due to the fall in the demand by the automotive, tire and footwear industry. The price of the synthetic rubber in January 2020 was 201.80 USD which fell to 192.00 USD in the month of April 2020 when the lockdown had increased the production activity have fallen down due to which the demand of the synthetic rubber have fallen down. In the month of May 2020 the price was 190.10 USD which again fell to 184.10 USD in the month of July 2020. CONCLUSION In 2020, COVID-19 has bad impact on the demand of footwear products due to which demand of footwear sole material product have fallen down. The demand of sports shoes, casual shoes have fallen down in all end-user segments which includes men, women and kids which resulted in low demand in footwear sole material in global market. The manufactures were able to earn revenue through the sale of footwear sole material for flip flops in the market during COVID-19. With the increase in sports and recreation activities and also with lifting of lockdown, the demand of different type of shoes in different industry will increase which will have positive impact on the demand of the footwear which is expected to boost the global footwear sole material market. Import and export of raw material and finished product of footwear products with other nations will help to boost global footwear sole material market in near future.
Bring Impeccable Changes In Remote Work
Regular Monitoring of the remote workforce brings a lot of wins for organizations. This can become a swift and simple task for all managers to provide a permanent value to the organization. It can also ensure that every team member is aware of the latest projects activities or even their responsibilities and make everyone understand what is happening around them, either inside or outside the organization. Thus, when managers have regular communication with their remote teams, it helps a lot, especially when problems happen unexpectedly. And when they have been able to discuss issues as soon as possible, the problem will not lead to significant disruptions that may affect the overall process. Remote Monitoring & its Benefits Remote Monitoring is a process of tracking employees’ activities, internal communication, and performance without making them feel observed. The aim is to achieve better business success through employee satisfaction. You can use just one tool or combine it if you have various remote locations with specific requirements. Let’s explore some of its benefits below - 1. Employers can easily monitor their employee’s performance remotely without having to check upon them physically. 2. Online time tracker helps you in getting better results from each employee. 3. It helps in knowing how much time a person has invested in a project and whether the schedule is maintained. 4. It is very helpful to get in touch with your team members’ performance status from time to time. In addition to the enumerated time benefits above, productivity time tracking software provides a diverse range of time management features such as the time entry feature (which means that you can enter time manually), time card creation, auto time input from emails, and many more. Reasons to track activities of your remote workforce 1. To minimize the distractions 2. Add surveillance for insider threats 3. To develop clear productivity directives for a remote team 4. Project Management Tracking 5. Create an extra layer of security for weak remote networks Which software should be used for employee monitoring? Monitoring and tracking Employee Productivity and performance can be complex, but the right software will show increased quality from your team. When choosing a monitoring tool, you need to make sure it fits your company culture for everyone in the office. A Time Tracker Software should be able to meet the following requirements- · Activity monitoring · Time tracking · Task tracking · Better employee management · Remote access · Time wasted reports · Better productivity · Clear timesheets WorkStatus is one of the best Employees Monitoring Software that meets all the above requirements. Also Read : How Can Regular Monitoring in Remote Work Bring Impeccable Changes?
How COVID-19 Impacted on Niemann-Pick Disease in Healthcare Industry ?
COVID-19 Impact on Niemann-Pick Disease in Healthcare Industry OVERVIEW A novel coronavirus, SARS-CoV-2, appeared in December 2019 in Wuhan, China, spreading much faster than its predecessors and has already infected millions of patients worldwide as of April 19, 2020. As the scope of the current COVID-19 outbreak has reached the proportion of pandemics, significant international efforts in public health are underway to control the epidemic. The covid-19 pandemic majorly impacted the rare diseases patients because, during the pandemic, the need to provide high-level care for a large number of patients with COVID-19 has affected resourcing and limited the routine maintenance of all other conditions. The impact of health emergencies particularly faced by the rare disease communities, organizations, clinics, and other healthcare providers. The health economic challenges faced by patients and their families, institutions, research organizations, and healthcare providers during the pandemic outbreak have demonstrated the importance of ensuring continuity of care in the management of rare diseases, including adequate diagnostics and monitoring protocols, and highlighted the need for a structured emergency strategy. Niemann-Pick disease is a rare, inherited disease that affects majorly body's ability to metabolize fats such as cholesterol and lipids within the cells. Over time, these cells got malfunctioned and died. The disease can affects the brain, spleen, nerves and, if get severe, may affect lungs, bone marrow, and other organs. The disease can occur at any age but majorly affects children. There is no known cure for the disease, and sometimes it may be fatal for children, the only treatment is focused on helping people live with their symptoms. IMPACT ON PRICE Various market players are facing a large number of challenges due to the coming of the novel coronavirus and different strains; one such issue is the uncertainty surrounding the impact of covid-19 on off label drugs demands. Due to the increased coronavirus cases and continuous lockdown, the costs of the drugs and their APIs increase automatically. On the one side, it will increase the revenue of the companies, but a patient may resist buying the products, which ultimately increases the stress level on the patients. Moreover, Due to the pandemic, there is the delay associated with various types of limitations faced by the manufacturers to fulfill the end product order, which has resulted in the less availability of medical devices in the market and due to which the cost of available devices has increased with the several factors. Also, due to the Coronavirus disease (COVID-19) pandemic outbreak, manufacturers are forced to find new contract manufacturers and suppliers for more manufacturing activities to different or unique facilities location that are less impacted by the outbreak. The impact of Covid-19 has created huge price impact on the government as well as on patient families that they have to buy the drugs on higher rate as compared to the average rate. IMPACT ON DEMAND The Coronavirus zone is the result of various markets around the world. This is the cause of the widespread closures and isolation that are affecting world economic activity. As the cases increases in the month of April 2020, the sudden surge in demand has seen, and drugs and medical devices went out of stock. Moreover, the decrease in the revenue of the key market players depicted in their quarterly results, such as Medtronic, among others, gave the evidence of decline in the demand for medical devices due to the emergence of the COVID-19 pandemic. For instance, · Medtronic reported a decline of 1% in its brain therapies net sales of the financial results of 2020 as compared to 2019. The reduction was primarily motivated by the detrimental effects of the COVID-19 pandemic and the subsequent deferral to companies of medical procedures. · Impact on rare disease organization also faced significant fundraising income loss, this consequential income loss may leads to loss of various people jobs associated with the organizations. The cutting or income loss leads to the reducing staff, canceling offices leases, and delay or cutting office programs. The impact of covid-19 majorly impacted the organizations if the revenues loss projections do not change, this will leads to temporarily or permanently shut down of small and middle foundations and organizations. IMPACT ON SUPPLY As the epidemic intensifies, supply chains can be at significant risk due to over-located locations that can potentially be disrupted. The supply chain of drugs, devices, and services has been disrupted. The spread of COVID-19 makes it difficult for governments to use these drugs; the availability of these systems faces constant challenges due to their components of use and limited initial needs. Moreover, as there is no cure for the disease, only physical activities/therapies may suppress the symptoms also affected by pandemics. According to the NORD (National Organization for Rare Disorders), in the U.S. stated that 74% of the population have had canceled medical appointments due to Covid-19 pandemic, 69% of population concerned about their medication and medical supplies. For instance, • In June, ResMed stated that, due to the Covid-19 pandemic company sleep apnea business segment adversely affected including sleep clinics, physician practices, HME suppliers. As new patients are prescribed sleep apnea devices such as PAP, CPAP devices for the treatment through hospitals that are directing their resources to critical care, including COVID-19 treatment. The covid 19 impacts may continue to decrease demand for the sleep apnea devices sale STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS As such, market participants are involved in the production of drugs, expanding their business through a variety of programs, including collaboration, contracts, and pipeline development, collaboration, and market expansion. It is expected that the strategic decisions of these companies will provide significant opportunities for market participants operating in the Niemann-Pick Disease market. For instance, · In July 2020, Abbott announced that it had received FDA approval for the use of the Patient Controller App on compatible personal Apple smartphone devices. The approval will allow the patient living with neurological conditions to manage their therapy directly from personal smartphone. · In May 2020, Philips, a global leader in health technology, joined forces with the American Telemedicine Association (ATA) to help further the adoption of telehealth across the industry, demonstrating its commitment to connecting care across acute, post-acute, and home care settings. The continued collaboration spotlights telehealth's growing adoption and momentum amidst COVID-19 and the need to convey the exponential shift to telehealth capabilities. · In U.S., NIH supports the research survey of “CURE EPILEPSY ORGANIZATION” to examine the impact of Covid-19 on Rare Disease Community. The survey includes more than 200 rare diseases including the brain, immune system disorders, heart, lungs, brain development diseases, and more. CONCLUSION As this pandemic situation has resulted in many restrictions in different places around the world, still the market players of dealing in rare diseases therapy and services were able to manage their service stock. Different companies dealing in metabolic diseases therapy services were finding out their own way to deal with this pandemic situation. The government and companies around the globe are working together and have issued advice for those undergoing therapies centers during these unprecedented times during COVID 19 lockdown around the world. The supply chain was destroyed, but several steps were taken by the government and companies, which will help them, get their needed output for therapy service. By increasing the material price, the companies can maintain their overall revenue. Thus, different foundations, organizations,, and services center markets are finding ways to deal with this pandemic situation. Figure 1: Relationship between Coronavirus and Lysosome storage diseases : Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway
How COVID-19 Impacted on Oral Care in Healthcare Industry ?
COVID-19 Impact on Oral Care in Healthcare Industry OVERVIEW The COVID-19 pandemic has posed a complex challenge in front of several healthcare companies and proved to be an unprecedented global health threat. This global pandemic has emerged in December 2019 which has been proved as a global pandemic by WHO in March 2020. With the development and introduction of novel coronavirus vaccine, COVID-19 cases have been declined but with the development of mutant coronavirus strain, the overall COVID-19 cases have been surged and are increasing at a rapid rate in India, and the U.K, and other European countries. The most common symptoms associated with this include cough, fever, diarrhea, sore throat, and loss of smell or taste. Patients affected with COVID-19 are at increased risk of developing hepatic manifestations and also experiences damage to liver tissues. COVID-19 has led to the closure and reduced hours of dental practices except for emergency and urgent services, limiting routine care and prevention. Dental care includes aerosol-generating procedures that can increase viral transmission. The pandemic offers an opportunity for the dental profession to shift more toward non-aerosolizing, prevention-centric approaches to care and away from surgical interventions. Direct effects of COVID-19 on oral health include ageusia (an official symptom of COVID-19) and case reports of vesiculobullous lesions and necrotizing periodontal disease. oral care product has a wide portfolio such as breath Fresheners, Mouth Wash, Dental Floss, among other products. The Article here shows the impact of COVID-19 on the oral care market. IMPACT ON PRICE As the mouth is an important place for bacterial colonization due to which it is necessary to use the product for oral hygiene. With the sudden increase in COVID-19 cases, people's concerns for better health had also increased and the link between oral health and COVID-19 infection also expand the health to oral. As India relies on China for 70% of API’s intermediates and bulk ingredients, COVID -19 is expected to hike the price of the ingredient used for an oral care product For instance, · In the year 2021, As Proctor & Gamble announced the third-quarter result in which the net sales increase by 5 %, and also mentioned that they are planning for a price hike in certain product divisions. This step is taken seeking to recover the revenue loss during COVID-19. · According to GlaxoSmithKline plc, the cost of dental consultation and treatment was cited as the concerning factor IMPACT ON DEMAND The coronavirus has affected the various regions of the world and caused the widespread closure of companies and local manufacturing plants. This lockdown and isolation have adversely impacted global economic activity. As studies around the world have shown the improving oral hygiene is expected to increase the chance of generating demand for the product. THE IMPACT OF COVID-19 INFECTION ON ORAL CARE The rising awareness of oral hygiene COVID-19 has increased the demand for a product requires for oral care as the increasing studies for SARS-COV-2 indicated that proper oral hygiene has been reported to decrease the chances of infection which increases the demand for mouth wash, oral povidone solution, novel gargle solution. · However, due to restrictions and aims to reduce COVID-19 transmission, 30% of respondents had visited a dentist less frequently during the pandemic The second cause of increasing demand for oral care products is that approximately 90% of the product used in oral care are over the counter which can be added as the plus point in maintaining the demand for oral care products. The market players in oral care are also focused on the research to bring novel products to interstate commerce. For instance, · Microbac Laboratories, an independent and internationally accredited testing facility worked on behalf of Unilever Research Laboratories, has found that rinsing with mouthwash containing CPC Technology for 30 seconds is effective in reducing the viral load of SARS-CoV-2, the virus that causes Covid-19, by 99.9%. This type of research surge the demand for the oral product · Colgate-Palmolive President mentioned in an interview that they have seen elevated demand for oral care related to viruses, which also boosted the innovative growth related to a premium product This suggests that the increasing prevalence of COVID-19 poses precautionary measures due to which the global population started to take concern for their health hence enhance the demand for oral care. This thus signifies that COVID-19 is accelerating the demand of the oral care market. IMPACT ON SUPPLY The COVID 19 pandemic has affected and badly disrupted the global drug supply chain due to the continuous shut down of manufacturing facilities and restrictions imposed by the government over import and export activities. As per global sources, it was found that the beauty care business is still facing a crisis due to COVID-19. However, oral care market players are in a strong position. The two main leaders Colgate-Palmolive and Johnson and Johnson had seen a lift in sales in Q1 2020. Colgate-Palmoliva has net sales of USD 415 million for Q3 2020, up by 5.5% from the previous year. The surge of demand for oral care increased during COVID-19 however, the global restriction, and state-wise travel restriction has caused challenges for the market player. Moreover, there are many local players also in the oral care market that continued to fulfill the demand in case of any disruption. Oral care is categorized under essential need products which leads to the easy flow of these products. The main challenges during the pandemic is the supply of API’s and Ingredient or excipient used in toothpaste, as China holds the major share in API’s and other chemicals used in oral care and global restriction has somehow affected the supply chain for these products too. This, thus signifies that due to continuous lockdown and several restrictions by government authorities the companies and patients are facing disruption of the supply chain for oral care. However, oral care is categorized under essential care which lowers the effect of supply chain disruption during COVID-19. STRATEGIC DECISIONS OF MANUFACTURERS Collaboration, agreements, strategic initiatives, product launches by market players such as Colgate Palmolive, Hindustan Unilever among others in the oral care market will help them to expand their product portfolio and to provide appropriate products to the consumer. This in turn will lead to increased product sales and hence will put a positive impact on the overall company’s revenue. Oral Care product manufacturing companies are taking so many strategic decisions to cope up with the current scenario of COVID-19. The companies engaged in the manufacturing of toothpaste, mouth wash, gargle solutions among others are adopting several initiatives to accelerate the development of newer products and efficiently supply the product to different end-users. Companies have done collaboration and product launches between 2019 -2020 which supports the sustainable growth in the oral care market For instance, · In September 2020, Colgate Palmolive launched as first-ever vedshakti mouth protect spray, seeking their focus on oral hygiene during COVID-19. · Hindustan Unilever also planned to launch a mouth wash with 99 % in reducing SARS-COV-2 virus and has recently shared the preliminary data. · In April 2020, GlaxoSmithKline Consumer Healthcare Limited (India) merged with Hindustan Unilever Limited (HUL), with HUL responsible for the distribution of GSK’s Consumer Healthcare brands in India, including its leading oral healthcare brand, Sensodyne. · In April 2020, Perrigo Company plc (Ireland) completed the acquisition of the oral care assets of High Ridge Brands (US), which includes Dr. Fresh, LLC. · In December 2019, Colgate-Palmolive Company launched Colgate Optic White Renewal Tooth Paste. · In 2020, Colgate-Palmolive comes up with a recyclable toothpaste tube which will increase the interest of the population and surge the demand for the product leading to growth in revenue of the company Thus, companies operating in the oral care market are adopting several strategies, including collaboration, agreements, acquisition, and market expansion to enhance their business. These strategic decisions by the companies are expected to provide significant opportunities for the market players operating in the oral care market. CONCLUSION As the pandemic of COVID-19 has resulted in several restrictions throughout the borders but still, manufacturers of oral care can manage their stocks. Various manufacturers have allowed their manufacturers to work in a clean and safe environment to boost up the production of oral care categorized under essential need products at various manufacturing facilities across several regions of the world helping them to maintain a continuous supply chain. However, a decrease in doctor’s visit has impacted the market but the majority of products used in oral care are over the counter product which leads to continuous demand for oral care, and by raising the prices the companies are gaining extra profit which is helping them to combat the negative effect on overall revenue.
How COVID-19 Impacted on Parenteral Nutrition in Healthcare Industry ?
COVID-19 Impact on Parenteral Nutrition in Healthcare Industry The COVID-19 pandemic has influenced the whole planet with its major impacts on the economy and businesses across the globe. The COVID-19 spread worldwide in unprecedented ways due to its high infectious and contagious nature and lack of availability of its vaccine. As a result, the greatest medical challenge in the 21st century is yet to be faced by physicians worldwide. Though the emergence of the virus can be traced back to Asia, many European countries along with the U.S. have been struck massively by the pandemic. The virus has spread across all regions ranging from North America, Europe, Asia-Pacific, Middle East, and Africa up to South America. The COVID-19 has been declared as a pandemic by World Health Organization (WHO) due to its increased spread across the globe. After the declaration of the pandemic, various countries announced the complete lockdown such as India, China, and other Asian countries to decrease its spread. According to the latest situation report by World Health Organization (WHO) stated 175 million cases of Corona have been reported globally and 4 million patients are dead due to the coronavirus. On a slightly positive note, a total of 158 million people have recovered and a total of 2 million vaccine doses have been administered as well. Parenteral nutrition is the medical term used for infusing a specialized form of food through a vein, intravenously. The objective of the treatment is to correct or prevent malnutrition by providing liquid nutrients, including carbohydrates, proteins, fats, vitamins, minerals, and electrolytes. Parenteral nutrition is used when the patient's gut cannot be used to absorb nutrients, the nutrition then must be delivered into the patient’s bloodstream, bypassing the gut. The reason for this type of feeding includes blockage of the gut, Perforations of the gut, parts of the bowel are diseased, or when a large part of the gut has been removed. COVID-19 has negatively impacted the market as trained professionals are required for the administration of such nutrition. But owing to the imposition of lockdown by the government, such administrations can’t be done that impacted negatively. The pandemic has affected the parenteral nutrition market in three ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. For instance, · In October 2020, the American Society for Parenteral and Eternal Nutrition issued the guidelines to update the use of filters for parenteral nutrition. The guidelines aim at reducing exposure to particulate matter during parenteral nutrition (PN) therapy by updating In-line intravenous filters. IMPACT ON DEMAND With the lockdown, all hospital admissions were stopped except the COVID-19 patients. Since the pandemic, lockdown situation the economic growth of the country is declining. And the manufacturing units for various items that are considered non-essential are shut down due to the non-availability of manpower. The pandemic has caused major destruction in the delivery of healthcare products across the world. It has posed limitations on many patients to access standard health services such as visits to healthcare professionals, medications, and diagnosis. It has adversely impacted the ability of patients and practitioners to adhere to treatment guidelines. Moreover, the demand for parenteral nutrition and growing awareness about current and new products is also fueling the market. For instance, · Otsuka Pharmaceutical Co. Ltd stated that in the pharmaceutical business, official requests to stay at home and urban lockdowns have led to a decrease in outpatient numbers in hospitals but there is an upward trend for long-term prescriptions for patients with chronic diseases. If the current situation were to be prolonged or become more serious, there may be a further decline in the number of new prescriptions and decline in prescriptions such as injections as part of hospital treatment due to restrictions on visits to health care facilities and the voluntary restraint on efforts to raise awareness of diseases, which may affect revenue. However, the negative impact of the pandemic on the parenteral nutrition market will be soon mitigated as different states/ countries allow medical clinics to reopen, services and once again being offered. IMPACT ON PRICE Due to the pandemic, the market is disturbed to a greater level. The several establishments have to remain shut while others scale down or put on hold expansion plans as they tried to survive the unprecedented crisis. Due to the impact of the coronavirus, many large pharmaceutical companies have placed new trials on hold and numerous small, mid-size, and large enterprises have suspended ongoing ones, thereby demonstrating the magnitude of the disruption. There have been uncertain past months due to the emergence of COVID-19. The sale of some company’s products experienced a downfall while others managed to stay afloat. For instance, · According to the annual report of Vifor Pharma Management Ltd., the sale of its products increased from USD 1794 million in 2019 to USD 1944.4 million in 2020 · According to the annual report of Otsuka Pharmaceutical Co. Ltd the nutraceuticals segment had a sale of USD 3,340.88 million with a business profit of 2.1 %. The total revenue in 2019 was USD 13,962.4 million which increased to USD 14,228.26 in 2020. As this lockdown has put manufacturers and distributors in worry as the key materials for the product, especially raw material supply are hindered; it will surely lead to change in prices up to an extent. IMPACT ON SUPPLY CHAIN As the world came to halt in the last few months due to the emergence of the pandemic, the supply chain couldn’t escape the impact. The government throughout the globe imposed total lockdown which led to supply chain disruptions. Consequently, the supply chain came to standstill due to the closure of borders. Even though the demand for parenteral nutrition remained untouched up to an extent, the availability was affected due to disruption in the supply chain, trade, and travel restrictions. Supply of raw material was also affected, due to which the product was affected. The outsourcing services which are providing warehousing, storage, and other services face challenges too. They are dependent on the logistic and transportation of chemical compound raw material from the outsourced service to the researchers' desk. However, with the sudden shut down globally with a ban in travel this process gets disrupted. Still, the companies managed to overcome the challenges and saw high growth. For instance, · According to the Annual report 2020 of Otsuka Pharmaceuticals Co. Ltd stated that concerning the procurement of raw materials, the purchasing channels overall are secure, although delays are occurring for some important items. Manufacturing had been temporarily suspended for some line items due to employees staying at home, but all manufacturing has been restored. The manufacturing operations are adequately staffed and proceeding smoothly. If the spread of COVID-19 were to be prolonged or become more serious causing stoppages in the procurement of raw materials, or if a cluster of infections or other similar cases occurred at a manufacturing plant, the supply of certain products may stop. However, the companies have been faced with substantial business and operational disruptions, which have included everything from mitigating the effects of reduced supply to managing disruptions to logistics suppliers, and indeed hurdle in meeting their contractual obligations to customers. The pandemic has forced the companies to rethink their supply chains and their stability and reliability for an uncertain future, including other externalities and government actions throughout the world, which have begun impacting supply chains, such as issues of sustainability. STRATEGIC INITIATIVES BY KEY PLAYERS As the reality of COVID-19 dawned upon the world, manufacturing and production unit of companies involved in parenteral nutrition key players formed strategies to mitigate with the limitations occurred due to the virus and keep their business running At the individual company level, companies are now more focused on operational resilience and accelerating initiatives that enable more agility, and transparency through the greater deployment of analytical tools and automation. Companies are considering re-evaluating their strategies, risk tolerance, and overall footprint. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand the market footprint. For instance, · In May 2021, Otsuka Pharmaceutical Co. Ltd announces that its affiliated company, Egypt Otsuka Pharmaceutical Co., S.A.E. (Egypt Otsuka), has agreed to jointly participate with a local pharmaceutical company Gypto Pharma for Trading and Pharmaceutical Manufacturing S.A.E. (Gypto) to establish a new company, Otsuka Gypto Pharmaceutical Egypt S.A.E. (Otsuka Gypto), which will sell ethical drugs such as IV solutions locally. However, to address the crisis all companies in this market are revisiting their financial trajectories and framing new strategies that will lead to bringing out solutions in the market resulting in increased business efficiency. CONCLUSION COVID-19 has impacted every sector with no exception global parenteral nutrition market has been affected the same. Different companies dealing in parenteral nutrition were finding out their way to deal with this pandemic situation. The government and companies around the globe are working together and have issued advice for those undergoing treatment for severe conditions during these unprecedented times during COVID-19 lockdown around the world. However, in the crisis call pharmaceuticals, key players, government bodies and healthcare organizations are working closely with healthcare professionals, customers, and patients for the betterment of public health. Thus, it is reasonable to assume that constraints on gathering and movement have disproportionally impacted people who use parenteral nutrition. However, healthcare industries and government bodies are exclusively concentrating on how they can make the effective and best contribution to control the spread of the virus and save lives. They are also ramping up the production of essential medicines to new levels and ensure that the speed doesn’t affect or destroy the quality of products.
[September-2021]Braindump2go New SC-200 PDF and VCE Dumps Free Share(Q82-Q88)
QUESTION 82 Hotspot Question You need to implement Azure Sentinel queries for Contoso and Fabrikam to meet the technical requirements. What should you include in the solution? To answer, select the appropriate options in the answer area. NOTE: Each correct selection is worth one point. Answer: QUESTION 83 You need to configure Microsoft Cloud App Security to generate alerts and trigger remediation actions in response to external sharing of confidential files. Which two actions should you perform in the Cloud App Security portal? Each correct answer presents part of the solution. NOTE: Each correct selection is worth one point. A.From Settings, select Information Protection, select Azure Information Protection, and then select Only scan files for Azure Information Protection classification labels and content inspection warnings from this tenant. B.Select Investigate files, and then filter App to Office 365. C.Select Investigate files, and then select New policy from search. D.From Settings, select Information Protection, select Azure Information Protection, and then select Automatically scan new files for Azure Information Protection classification labels and content inspection warnings. E.From Settings, select Information Protection, select Files, and then enable file monitoring. F.Select Investigate files, and then filter File Type to Document. Answer: DE QUESTION 84 You use Azure Security Center. You receive a security alert in Security Center. You need to view recommendations to resolve the alert in Security Center. What should you do? A.From Security alerts, select the alert, select Take Action, and then expand the Prevent future attacks section. B.From Security alerts, select Take Action, and then expand the Mitigate the threat section. C.From Regulatory compliance, download the report. D.From Recommendations, download the CSV report. Answer: B QUESTION 85 You have a suppression rule in Azure Security Center for 10 virtual machines that are used for testing. The virtual machines run Windows Server. You are troubleshooting an issue on the virtual machines. In Security Center, you need to view the alerts generated by the virtual machines during the last five days. What should you do? A.Change the rule expiration date of the suppression rule. B.Change the state of the suppression rule to Disabled. C.Modify the filter for the Security alerts page. D.View the Windows event logs on the virtual machines. Answer: B QUESTION 86 You are investigating an incident in Azure Sentinel that contains more than 127 alerts. You discover eight alerts in the incident that require further investigation. You need to escalate the alerts to another Azure Sentinel administrator. What should you do to provide the alerts to the administrator? A.Create a Microsoft incident creation rule B.Share the incident URL C.Create a scheduled query rule D.Assign the incident Answer: D QUESTION 87 You are configuring Azure Sentinel. You need to send a Microsoft Teams message to a channel whenever an incident representing a sign-in risk event is activated in Azure Sentinel. Which two actions should you perform in Azure Sentinel? Each correct answer presents part of the solution. NOTE: Each correct selection is worth one point. A.Enable Entity behavior analytics. B.Associate a playbook to the analytics rule that triggered the incident. C.Enable the Fusion rule. D.Add a playbook. E.Create a workbook. Answer: AB QUESTION 88 You have the following environment: - Azure Sentinel - A Microsoft 365 subscription - Microsoft Defender for Identity - An Azure Active Directory (Azure AD) tenant You configure Azure Sentinel to collect security logs from all the Active Directory member servers and domain controllers. You deploy Microsoft Defender for Identity by using standalone sensors. You need to ensure that you can detect when sensitive groups are modified in Active Directory. Which two actions should you perform? Each correct answer presents part of the solution. NOTE: Each correct selection is worth one point. A.Configure the Advanced Audit Policy Configuration settings for the domain controllers. B.Modify the permissions of the Domain Controllers organizational unit (OU). C.Configure auditing in the Microsoft 365 compliance center. D.Configure Windows Event Forwarding on the domain controllers. Answer: AD 2021 Latest Braindump2go SC-200 PDF and SC-200 VCE Dumps Free Share: https://drive.google.com/drive/folders/1IE9DMPPLO4DhDEbH-R7ugD_zKUjJxFsH?usp=sharing